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Background: Conflicting results exist about the meaning of exhaled nitric oxide (eNO) in epidemiologic studies, mainly
because of the numerous factors that may affect the measurement.
Objectives: To evaluate the role of the factors that influence eNO levels in a sample of schoolchildren with or without
respiratory diseases. We studied 335 schoolchildren, ages 10 to 16 years, from 8 schools in Palermo, Italy. After a respiratory
questionnaire was completed, spirometry, skin tests, and eNO measurements were performed.
Results: Among 335 children, 13.7% reported symptoms of bronchial asthma, 46.9% reported symptoms of rhinitis, and
39.4% were asymptomatic. The ratio of forced expiratory volume in 1 second to forced vital capacity was 87.6% (SD, 6.4%) in
the bronchial asthma group, 90.6% (SD, 5.0%) in the rhinitis group, and 90.4% (SD, 5.1%) in the asymptomatic group (P 
.002). Atopic children constituted 52.2% of the bronchial asthma group, 40.1% of the rhinitis group, and 28.8% of the
asymptomatic group. Among atopic children, 102 (82%) had a positive skin test result for Dermatophagoides. Median eNO was
12.6 ppb in nonatopic children and 21.2 ppb in atopic children (P  .001, by Mann-Whitney U test). Among asymptomatic
children, atopic children had significantly higher eNO levels than did nonatopic children (P  .001). In nonatopic children, no
difference was found in log transformation eNO among healthy, rhinitic, or asthmatic children. Log transformation eNO
increased with the number of positive skin test results (P  .001). Atopy, asthma, male sex, and indoor allergens were predictors
of increased eNO in a logistic model.
Conclusions: Atopy (in particular, sensitization to indoor and perennial allergens) is strongly associated with higher eNO
levels. Such association is enhanced by asthma.
Ann Allergy Asthma Immunol. 2008;101:407–412.
INTRODUCTION
Exhaled nitric oxide (eNO) has been proposed as a noninva-
sive marker of airway inflammation in asthma and respiratory
allergy, and its use is currently increasing, in view of its
relatively simple procedure. The latter represents an addi-
tional advantage, especially in the pediatric population. Fur-
thermore, the measurement of eNO has been suggested as a
valuable tool in adjusting asthma therapy according to in-
flammation. Increased levels of eNO have been found in
asthmatic children1 and in asymptomatic atopic children.2–4
Consequently, it has been suggested that the relation between
asthma and increased eNO levels may be mediated by atopy
itself.5 This suggestion emphasizes the key role of atopic
inflammation in determining an increase in eNO production
for allergic diseases such as asthma and rhinitis.6,7
Nevertheless, some conflicting results exist about the
meaning of eNO measures in epidemiologic studies. In fact,
some authors did not find any difference in eNO levels
between atopic and nonatopic healthy individuals.1,8 Con-
versely, other studies demonstrated a linear or dose-response
relation between the degree of skin test positivity and eNO
levels.2,4,7 The relative weight of some factors (atopy, clinical
disease, number of positive skin test results) remains to be
determined. The aim of the present study was to identify the
determinants of high eNO levels in a sample of schoolchil-
dren with and without respiratory disease.
METHODS
Patient Population
This was a cross-sectional study conducted in a sample of
schoolchildren, ages 10 to 16 years, from 8 junior high
schools in Palermo, Southern Italy, in 2004. The whole
student population of the 8 schools was 4,711 children.
Among them, we randomly selected 1,177 children for the
study (1 for every 4). One hundred twenty-seven children did
not obtain parental consent or were not present at school on
the day of the study. Thus, 1,050 children completed the
respiratory health questionnaire9 and underwent lung function
testing and skin prick testing at school. One third of 1,050
children (1 of every 3 children; total, 350) were selected for
eNO testing in our laboratory. Fifteen children were excluded
because of recent upper or lower respiratory tract infections
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or insufficient cooperation in performing eNO measures.
Thus, we obtained eNO measurements in 335 children. Ex-
cept for asthma, no other chronic pulmonary disease was
reported, and no child was taking oral or inhaled steroids. The
study was approved by the institutional ethics committee. All
parents of the children signed a written informed consent
form. According to Italian law, respect for individual privacy
concerning clinical data was granted.
Study Parameters
A history of physician-diagnosed asthma was defined as a
positive answer to the question, “Have you ever had asthma
diagnosed by a physician?” Rhinitis was defined as a positive
answer to the question, “Have you ever had sneezing, or
runny, or blocked nose apart from common cold or flu?”
Based on these criteria, children were subdivided into 3
subgroups: asthmatic children, rhinitic children, and control
children, that is, children without asthma or rhinitis.
Skin tests were performed according to international
recommendations with a standard panel, including Der-
matophagoides mix, grass mix, Parietaria judaica, Com-
positae mix, olive, dog and cat dander, Alternaria, and
Blattella germanica, plus a positive (histamine 1%) and a
negative (saline) control (Stallerge`nes Italia S.r.l., Milan,
Italy). The positivity was measured after 15 minutes, and
reactions were considered positive if the wheal was 3 mm
or greater in its larger diameter, in the presence of a
negative reaction to the saline control.10 Atopy was defined
as the presence of at least 1 positive skin prick test result.
Children were grouped into 3 different groups according to
the number of the positive skin prick test results: non-
atopic, 1 positive skin prick test result, or 2 or more
positive skin prick test results.
Height and weight were measured in all the children, and
body mass index was calculated as weight in kilograms
divided by height in meters squared. Pulmonary function tests
were performed with the use of a portable spirometer (Mi-
croLoop, Micro Medical; Chatham Maritime, Kent, En-
gland). Forced expiratory volume in 1 second (FEV1) and
forced vital capacity (FVC) were measured according to
American Thoracic Society guidelines, and the best (largest
sum of FVC and FEV1) of 3 technically acceptable and
reproducible maneuvers was retained.11
Nitric Oxide Measurements
On a different day, fractional eNO concentrations were mea-
sured in our medical laboratory by a chemiluminescence
analyzer connected to a computerized system (NIOX; Aero-
crine AB, Stockholm, Sweden). The instrument had a sensi-
tivity of 1.5 ppb, a detection range of 0 to 200 ppb, and a
response time less than 0.8 second. The instrument was
calibrated with a certified NO gas mixture. The online single
exhalation technique provided automatic control of exhala-
tion to a constant flow rate of 50 mL/s, according to Amer-
ican Thoracic Society recommendations.12 During exhalation,
positive pressure provided closure of the velum, preventing
contamination of the sample with nasal NO. The mean eNO
value of 3 valid measurements was recorded for each partic-
ipant.
Table 1. Descriptive Data of the Total Sample and Study
Populationa
Variable
Total sample
(N  1,050)
Study population
(n  335)
Female/male, No. 573/477 191/144
Age, mean (range), y 12.2 (10–17) 12.1 (10–16)
Asthmatic, No. (%) 129 (12.3) 46 (13.7)
Rhinitic, No. (%) 491 (46.8) 157 (46.9)
Control, No. (%) 430 (40.9) 132 (39.4)
Atopy, No. (%) 329 (31.3) 125 (37.3)
FVC, mean (SD), L 3.06 (0.64) 2.97 (0.58)
FVC, mean (SD),
% predicted
98.7 (11.8) 98.0 (11.5)
FEV1, mean (SD), L 2.74 (0.55) 2.66 (0.49)
FEV1, mean (SD),
% predicted
99.0 (11.6) 98.7 (10.8)
FEV1/FVC, mean (SD), % 89.7 (5.7) 90.1 (5.34)
FEV1/FVC, mean (SD),
% predicted
100.5 (6.2) 100.9 (5.9)
Abbreviations: FVC, forced vital capacity; FEV1, forced expiratory
volume in 1 second.
a All differences are not statistically significant (2 test for categorical
variables and analysis of variance for continuous variables).
Table 2. Atopy, Respiratory Function, and eNO Data for Each Clinical Subgroup
Variable
Control patients
(n  132)
Rhinitic patients
(n  157)
Asthma patients
(n  46)
Atopic children, No. (%) 38 (28.8)a 63 (40.1)a 24 (52.2)a
FEV1/FVC, mean (SD), % 90.4 (5.10) 90.6 (5.03) 87.6 (6.41)b
FEV1/FVC, mean (SD), % predicted 101.5 (5.5) 101.3 (5.5) 97.9 (7.0)b
eNO in atopic children, median (range), ppb 17.4 (5.5–95.2) 19.1 (5.8–92.5) 48.8 (8.2–88.0)c
eNO in nonatopic children, median (range), ppb 13.1 (3.0–71.0) 12.6 (2.8–71.8) 11.0 (3.8–28.9)
Abbreviations: eNO, exhaled nitric oxide; FVC, forced vital capacity; FEV1, forced expiratory volume in 1 second.
a P  .01 (2 test).
b P  .002 compared with controls and rhinitic children (analysis of variance).
c P  .001 compared with controls and rhinitic children (Mann-Whitney U test). Unless otherwise indicated, differences are not significant.
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Statistical Analyses
Analysis of variance and frequency distribution tables (2
test) for parametric variables were performed. Because the
distribution of eNO values was highly skewed, results were
expressed as values after natural log transformation (ln eNO).
Correlations among variables were investigated by simple
linear regression analysis. To study the independent variables
able to influence the risk for elevated eNO levels, eNO was
dichotomized at the level of the 75th percentile and the
logistic regression model was used to explore the relation
between the dependent variable (eNO) and independent vari-
ables (atopy, asthma, and sex), adjusting for confounding
variables (pulmonary function, lung size, and height). For this
purpose, continuous independent variables were dichoto-
mized at the level of the 50th percentile of their distribution.
All computations were performed with the use of the Stat-
View statistical software package (SAS Institute Inc, Cary,
North Carolina). P  .05 was selected as statistically signif-
icant.
RESULTS
Participants (n  335) in whom eNO measurement was
performed were not significantly different compared with the
whole sample (N  1,050) regarding age, sex, atopy, rhinitis
and asthma distribution, FVC, FEV1, and FEV1/FVC (Table
1). In the studied sample, mean FEV1, in percentage of
predicted, was 98.7% (SD, 10.8%) and FEV1/FVC was
90.1% (SD, 5.34%). There were 125 atopic children (37.3%).
No significant difference in the prevalence of atopy was
found between the sexes (Table 1). Among atopic children,
102 (82%) had a positive skin test result for Dermatopha-
goides.
As indicated in Table 2, 46 of 335 children (13.7%) re-
ported asthma with or without rhinitis, 157 (46.9%) reported
rhinitis alone, and the remaining 132 (39.4%) were asymp-
tomatic. Asthmatic children had a significantly lower FEV1/
FVC (analysis of variance, P  .002) compared with asymp-
tomatic and rhinitic children. The prevalence of atopy, as
defined herein, was 28.8% in asymptomatic (control) chil-
dren, 40.1% in rhinitic children, and 52.2% in asthmatic
children (P  .01, 2 test).
Atopic children, regardless of clinical presentation, had
significantly higher eNO than did nonatopic children (Fig 1):
median (interquartile range) eNO was 12.6 ppb (9.3–15.7
ppb) in nonatopic children and 21.2 ppb (13.2–44.3 ppb) in
atopic children (P  .001, by Mann-Whitney U test). Among
those atopic children, asthmatic children showed the highest
ln eNO mean value (3.69, P  .001, by analysis of variance)
(Fig 1), which was significantly different from rhinitic and
control children. Conversely, no significant difference was
found between rhinitic and control children. When consider-
ing nonatopic children, no significant difference was found
for ln eNO among control, rhinitic, or asthmatic children (by
analysis of variance) (Fig 1).
As mentioned herein, children were divided into 3 different
groups according to skin positivity (nonatopic, 1 positive skin
test result, and 2 or more positive skin test results). The level
of ln eNO was significantly increased in children with 1
positive prick test result and even higher in children with
multiple positive skin test results compared with nonatopic
children. Differences in eNO levels among the 3 skin prick
groups are shown in Figure 2. The linear correlation between
ln eNO and number of positive skin test results (as continuous
variable) was statistically significant (P  .001), both in the
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Figure 1. Values of exhaled nitric oxide (eNO) (as natural log) in atopic
and nonatopic children of each subgroup: asymptomatic (control) children,
rhinitic children, and asthmatic children. No significant differences were
found among nonatopic children (2-way analysis of variance). Bars indicate
(from bottom to top) 10th, 25th, 50th (median), 75th, and 90th percentiles.
Values below 10th and above 90th percentiles are plotted as circles. For each
subgroup, the number of children is indicated (#). *P  .001.
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Figure 2. Values of exhaled nitric oxide level (eNO) are shown separately
for nonatopic children (0), for children with only 1 positive skin test result
(1), and for children with 2 or more positive skin test results (2). Bars
indicate (from bottom to top) 10th, 25th, 50th (median), 75th, and 90th
percentiles. Values below 10th and above 90th percentiles are plotted as
circles. *P  .001 (differences among groups were computed by analysis of
variance after natural log transformation).
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overall sample and in each subgroup (control children: r 
.449; rhinitic children: r  .381; and asthmatic children: r 
.677).
Using the simple linear regression analyses, we did not
find any relation between ln eNO (as the dependent variable)
and height, FVC, FEV1 (percentage of predicted), FEV1/FVC,
and FEV1/FVC (percentage of predicted) as independent vari-
ables. When eNO was used as the dependent variable in a
logistic model, the presence of atopy (odds ratio [OR], 7.63;
95% confidence interval [CI], 4.24–13.74; P  .001), the
presence of asthma (OR, 3.34; 95% CI, 1.54–7.24; P 
.001), and male sex (OR, 2.21; 95% CI, 1.23–3.97; P .001)
were significant predictors of increased eNO, after adjust-
ment for FEV1/FVC, FVC, and height. To evaluate the inter-
action between presence of atopy and asthma, we introduced
into the logistic model a categorical variable in 4 levels (0, no
atopy, no asthma, n  188 [reference category]; 1, asthma
without atopy, n 22; 2, atopy without asthma, n 101; and
3, atopy with asthma, n  24). The ORs (95% CIs) were 0.5
(0.05–3.9) for level 1, 5.1 (2.8–9.5) for level 2, and 64.1
(16.8–244.9) for level 3. Among allergens, Dermatopha-
goides and cat dander were significant predictors of increased
eNO when adjusted for sex and the presence or absence of
asthma and rhinitis (Table 3).
DISCUSSION
This cross-sectional study in schoolchildren demonstrates
that atopy, sensitization to indoor allergens, asthma, and male
sex are significant predictors for increased eNO levels in
children from a general population. With regard to internal
validity, no significant difference was found among the
whole sample and the children in whom eNO measurements
were performed regarding age, sex, atopy, rhinitis and asthma
distribution, FVC, FEV1, and FEV1/FVC.
Levels of eNO are higher in atopic than in nonatopic
children. Furthermore, a significant relation exists between
eNO levels and number of positive skin test results. In addi-
tion, only indoor perennial allergens (ie, Dermatophagoides
and cat dander) are associated with significantly increased
eNO levels. Furthermore, the highest eNO levels are ob-
served in atopic children with physician-diagnosed asthma. In
particular, even in the subgroup of asymptomatic individuals,
atopic individuals have significantly higher eNO levels (the
median eNO was 33% higher in asymptomatic atopic chil-
dren than in nonatopic children). This finding suggests that
atopy per se is able to significantly influence eNO levels.
Similar results were previously reported in both adults13,14 and
children.2–4 However, other studies did not find a relation
between atopy and eNO levels in children.1,5,15 In particular,
Latzin et al15 failed to demonstrate a relation between atopy
and eNO levels in 4- to 18-year-old healthy children. A
possible explanation for these conflicting results might be
found in the dimension of the studied sample,5 the different
prevalence of atopic children in the study samples, and the
different age distributions.15 In fact, in our study, the preva-
lence of atopy was 29% among asymptomatic children, and
the age range was 10 to 16 years: The corresponding figures
in the study by Latzin et al were 46% and 4 to 18 years,
respectively.
We found that boys have significantly higher eNO levels
than do girls. This result is in agreement with the works of
Barreto et al4 and Wong et al,16 who recently demonstrated a
sex difference in eNO levels in schoolchildren. Similarly,
Nordvall et al,17 in a large population sample, found a sig-
nificantly higher eNO in boys than in girls. The authors
attributed this finding to a possible role of larger lung vol-
umes in boys. However, after correcting also for FVC, as an
index of lung volume, in our logistic model, we found that
male sex maintains a significant effect in increasing eNO
values. Nevertheless, controversial results exist on the rela-
tion between sex and eNO levels; in fact, in some studies no
association was found between sex and eNO.18,19 In the study
by Malmberg et al,18 the authors demonstrated that height was
a strong predictor of increased eNO in healthy children. The
latter association was not found in our study. The difference
may be due to the wider age range (7–16 years) in the study
by Malmberg et al, producing a wider height range. Similarly,
Buchvald et al20 found a significant correlation between eNO
levels and age. We did not find such correlation. Once more,
this difference may be explained by the wider age range
(4–17 years) in the study by Buchvald et al.
Our results show that children with rhinitis alone do not
have eNO values significantly different from control chil-
dren, both in atopic and nonatopic subgroups (Fig 1). Con-
versely, Jouaville et al1 demonstrated that atopic children
with rhinitis have higher eNO levels than do atopic control
children. This difference may be explained by the method-
ologic differences in eNO measurement and by the smaller
sample size in the study by Jouaville et al. Buchvald et al,20
in a sample of 405 children ages 4 to 17 years, showed a
significant difference between rhinitic and control children.
In the latter study, however, the presence of atopy was
evaluated on the basis of self-reported symptoms.
It is noteworthy that asthmatic, nonatopic children show
eNO levels close to those of nonatopic rhinitic and asymp-
tomatic children. This finding is in agreement with the study
Table 3. Multiple Logistic Regression Analysis (Association With
Increase in Exhaled Nitric Oxide Levels, Cutoff Level at 75th
Percentile)
Allergen OR (95% CI)a P value
Dermatophagoides 6.18 (3.26–11.7) .001
Cat dander 8.70 (1.93–39.14) .005
Parietaria 1.30 (0.41–4.08) .65
Alternaria 4.10 (0.34–49.09) .26
Grass pollen 0.74 (0.19–2.85) .66
Compositae 1.16 (0.04–30.96) .93
Olea 0.76 (0.18–3.13) .71
Blattella germanica 1.84 (0.15–22.80) .63
Abbreviations: CI, confidence interval; OR, odds ratio.
a Data are expressed as OR adjusted for sex, asthma, and rhinitis.
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by Ludviksdottir et al,21 who did not observe any significant
difference in eNO between nonasthmatic control patients and
nonatopic adult asthmatic patients. Furthermore, when rhini-
tis and especially asthma were associated with atopy, we
found much greater eNO levels; in fact, median eNO in
atopic, asthmatic patients was approximately 4-fold higher
than the level of nonatopic, asthmatic patients (Table 2).
Thus, the association of asthma and atopy appears to be the
most consistent predictor of increased eNO level. A similar
result was obtained by Frank et al,5 who found that the eNO
geometric mean was significantly higher in children with
atopic asthma than in nonatopic asthmatic children. These
findings further support the hypothesis that in children atopy
is a major determinant of increased eNO levels, mainly when
associated with clinical manifestation of asthma. In other
words, atopy and asthma appear as cofactors in determining
elevated eNO levels.
In the present study, we also found that eNO level in-
creased with the number of positive skin prick test results
regardless of clinical status; in fact, when the number of
individual positive skin prick test results was used as the
continuous independent variable, the linear regression with
eNO (as the dependent one) was significant both in the
overall sample and in each subgroup (ie, allergic, rhinitic, and
control children). This result is consistent with previous stud-
ies demonstrating the effect of the number of positive skin
test results on the level of eNO.1,2,4,7,22 In particular, Franklin
et al2 found that in healthy children eNO levels were higher
in those with a positive skin prick test result and even higher
in children with more than 1 positive skin test result, sug-
gesting that allergen sensitization may play a significant role
in elevating eNO production in the respiratory tract.
The logistic analysis model also showed that after adjust-
ing for confounding variables, only sensitization to Dermato-
phagoides and cat dander influence eNO levels. Similarly,
Leuppi et al23 showed that in atopic children, an increased
eNO level is associated with sensitization to perennial aller-
gens but not with seasonal allergens. In addition, Barreto et
al19 reported no difference in eNO levels between nonatopic
and atopic children sensitized to grass pollen. Thus, sensiti-
zation to indoor perennial allergens appears to affect eNO
production in the respiratory tract, possibly through long-
lasting inflammatory stimuli, regardless of clinical respira-
tory manifestations. This finding is in agreement with the
study by Gratziou et al,6 who suggested that eNO levels
mainly reflect the allergic origin of inflammation in the
airways.
In conclusion, atopic status is strongly associated with high
eNO levels, even in asymptomatic individuals. The relation
between atopy and eNO levels indicates that eNO measure-
ments may help to clarify the relevant role of sensitization in
the complex interplay of multiple factors determining the
translation into clinical allergy. Furthermore, this finding also
helps to address the problem of asymptomatic allergen sen-
sitization vs clinical allergy, also envisaging the possible role
of eNO measurement as a noninvasive screening test for early
detection of individuals prone to have clinical allergy. In
particular, the sensitization to indoor perennial allergens ap-
pears to be one of the main determinants of high eNO levels.
Furthermore, the eNO levels were positively correlated with
the number of positive skin prick test results. Consequently,
we recommend performing eNO measurements in epidemio-
logic studies on respiratory diseases in children, taking into
account the individual’s atopic status. The development of
new portable instruments for eNO monitoring24 opens new
perspectives to widespread use of such measurements in
epidemiology.
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